Denmark· DK-28101020079
Linco-spectin Vet.
A qj01ff52 product containing lincomycinhydrochlorid, spectinomycinsulfattetrahydrat, registered in Denmark by Phibro Animal Health (Poland) Sp. z o.o..
Checked against Danish Medicines Agency (Denmark) on
Informational only — not a medical device.
The record
At a glance
Danish Medicines Agency (Denmark)- Active substance
- Lincomycinhydrochlorid, Spectinomycinsulfattetrahydrat
- Manufacturer
- Phibro Animal Health (Poland) Sp. z o.o.
- Country
- Denmark (DK)
- ATC code
- QJ01FF52
- ATC class
- QJ01FF52
- Reimbursed
- Not published by this register
- Source register
- Danish Medicines Agency (Denmark)
- Last checked
- September 30, 2026
Packs & prices · 1
- dk_varenummer28101020079
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same class
Other records under QJ01FF52
Qj01ff52, as other registers publish it.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Danish Medicines Agency (Denmark). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/204cc684-e96a-48b4-bb87-d4a03c4e38ce GET /v1/drugs/204cc684-e96a-48b4-bb87-d4a03c4e38ce?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "pulver til opløsning i drikkevand",
"source": "dkma",
"strength": "220 + 440 mg/g",
"auth_role": "CMS",
"dk_drugid": "28101020079",
"substance": "Lincomycinhydrochlorid, Spectinomycinsulfattetrahydrat",
"auth_procedure": "MRP",
"in_medicinpriser": true,
"registration_date_serial": "29311"
}See everything about lincomycinhydrochlorid, spectinomycinsulfattetrahydrat.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.